Teladoc | Stigma of Diabetes and Weight Management-Weight Management Treatment Options Infographic

Weight Management Treatment Options Infographic

Pdf Summary

This document is a visual guide to weight management treatment options based on the American Diabetes Association's (ADA) Standards of Care in Diabetes for 2023. It provides information on different pharmacological agents and lifestyle modifications that can be used to manage weight in individuals with type 2 diabetes.<br /><br />The document emphasizes the importance of setting specific, measurable, actionable, timely, and realistic (SMART) goals when counseling people with diabetes. Behavioral strategies are recommended to support diabetes self-management and engagement in health behaviors to promote optimal diabetes health outcomes.<br /><br />The pharmacological agents mentioned include phentermine, phentermine/topiramate ER, naltrexone/bupropion ER, liraglutide, and semaglutide. Each medication is described along with its common side effects and possible safety concerns/considerations. These range from dry mouth and insomnia to contraindications for use with other medications and potential liver or kidney injury.<br /><br />The document also mentions orlistat, a lipase inhibitor, as an anti-obesity medication. It highlights the need for a person-centered approach to weight management and the importance of addressing individual needs and preferences.<br /><br />Overall, this document provides a comprehensive overview of weight management treatment options for individuals with type 2 diabetes, including both pharmacological agents and lifestyle modifications. It highlights the importance of setting SMART goals and taking a person-centered approach to ensure optimal diabetes health outcomes.

Keywords

weight management treatment options

American Diabetes Association

ADA Standards of Care in Diabetes

pharmacological agents

lifestyle modifications

SMART goals

diabetes self-management

phentermine

naltrexone/bupropion ER

orlistat